He says this average comes from his own clinical experience, adding that some strong responders drop more than 10 kg. A personal observation, not trial data.
Recap by typeshit. Post by Karthik Balachandran on X.
Popular Mechanics traces how her 1980s work at Mass General showed GLP-1 triggers insulin release. Gallup now puts GLP-1 weight loss use at about 11% of Americans.
Barzilai highlights trial results on retatrutide in adults with sleep apnea and obesity or overweight, a new use being tested for Lilly's drug.
The Washington meeting runs November 14 to 17, with primary REDEFINE 9 results and pediatric semaglutide research for kids 6 to under 12.
Researchers tracked spending on drinks while out and found a sharp drop among people taking GLP-1 medications.
On Business Insider's The Long Play, Reitano walks through nine years of strategy shifts that moved Ro from telehealth toward GLP-1 care.
Known for cancer blockbusters, AstraZeneca is chasing the market built by Wegovy and Mounjaro with a weight loss drug of its own.
Loading…